Cargando…

Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China

PURPOSE: To investigate the interobserver variability (IOV) in target volume delineation of definitive radiotherapy for thoracic esophageal cancer (TEC) among cancer centers in China, and ultimately improve contouring consistency as much as possible to lay the foundation for multi-center prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Xiao, Deng, Wei, Wang, Xin, Zhou, Zongmei, Yang, Jun, Guo, Wenling, Liu, Miaoling, Qi, Xiaolu, Li, Ling, Zhang, Kaixian, Zhang, Min, Shi, Yonggang, Liu, Ke, Zhao, Yidian, Wang, Huitao, Yu, Zhilong, Zhang, Jihong, Wang, Lihua, Qiao, Xueying, Han, Chun, Zhu, Shuchai, Zhang, Ruohui, Chen, Junqiang, Hu, Cairong, Zhang, Fuquan, Hou, Xiaorong, Pang, Qingsong, Zhang, Wencheng, Li, Gaofeng, Lin, Hailei, Sun, Xinchen, Ge, Xiaolin, Li, Caihong, Ge, Hong, Li, Dingjie, Wang, Yadi, Lu, Na, Gao, Xianshu, Qin, Shangbin, Tian, Yuan, Xiao, Zefen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188796/
https://www.ncbi.nlm.nih.gov/pubmed/34107984
http://dx.doi.org/10.1186/s13014-020-01691-4
_version_ 1783705398052651008
author Chang, Xiao
Deng, Wei
Wang, Xin
Zhou, Zongmei
Yang, Jun
Guo, Wenling
Liu, Miaoling
Qi, Xiaolu
Li, Ling
Zhang, Kaixian
Zhang, Min
Shi, Yonggang
Liu, Ke
Zhao, Yidian
Wang, Huitao
Yu, Zhilong
Zhang, Jihong
Wang, Lihua
Qiao, Xueying
Han, Chun
Zhu, Shuchai
Zhang, Ruohui
Chen, Junqiang
Hu, Cairong
Zhang, Fuquan
Hou, Xiaorong
Pang, Qingsong
Zhang, Wencheng
Li, Gaofeng
Lin, Hailei
Sun, Xinchen
Ge, Xiaolin
Li, Caihong
Ge, Hong
Li, Dingjie
Wang, Yadi
Lu, Na
Gao, Xianshu
Qin, Shangbin
Tian, Yuan
Xiao, Zefen
author_facet Chang, Xiao
Deng, Wei
Wang, Xin
Zhou, Zongmei
Yang, Jun
Guo, Wenling
Liu, Miaoling
Qi, Xiaolu
Li, Ling
Zhang, Kaixian
Zhang, Min
Shi, Yonggang
Liu, Ke
Zhao, Yidian
Wang, Huitao
Yu, Zhilong
Zhang, Jihong
Wang, Lihua
Qiao, Xueying
Han, Chun
Zhu, Shuchai
Zhang, Ruohui
Chen, Junqiang
Hu, Cairong
Zhang, Fuquan
Hou, Xiaorong
Pang, Qingsong
Zhang, Wencheng
Li, Gaofeng
Lin, Hailei
Sun, Xinchen
Ge, Xiaolin
Li, Caihong
Ge, Hong
Li, Dingjie
Wang, Yadi
Lu, Na
Gao, Xianshu
Qin, Shangbin
Tian, Yuan
Xiao, Zefen
author_sort Chang, Xiao
collection PubMed
description PURPOSE: To investigate the interobserver variability (IOV) in target volume delineation of definitive radiotherapy for thoracic esophageal cancer (TEC) among cancer centers in China, and ultimately improve contouring consistency as much as possible to lay the foundation for multi-center prospective studies. METHODS: Sixteen cancer centers throughout China participated in this study. In Phase 1, three suitable cases with upper, middle, and lower TEC were chosen, and participants were asked to contour a group of gross tumor volume (GTV-T), nodal gross tumor volume (GTV-N) and clinical target volume (CTV) for each case based on their routine experience. In Phase 2, the same clinicians were instructed to follow a contouring protocol to re-contour another group of target volume. The variation of the target volume was analyzed and quantified using dice similarity coefficient (DSC). RESULTS: Sixteen clinicians provided routine volumes, whereas ten provided both routine and protocol volumes for each case. The IOV of routine GTV-N was the most striking in all cases, with the smallest DSC of 0.37 (95% CI 0.32–0.42), followed by CTV, whereas GTV-T showed high consistency. After following the protocol, the smallest DSC of GTV-N was improved to 0.64 (95% CI 0.45–0.83, P = 0.005) but the DSC of GTV-T and CTV remained constant in most cases. CONCLUSION: Variability in target volume delineation was observed, but it could be significantly reduced and controlled using mandatory interventions. SUPPLEMENTARY INFORMATION: Supplementary information accompanies this paper at 10.1186/s13014-020-01691-4.
format Online
Article
Text
id pubmed-8188796
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81887962021-06-10 Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China Chang, Xiao Deng, Wei Wang, Xin Zhou, Zongmei Yang, Jun Guo, Wenling Liu, Miaoling Qi, Xiaolu Li, Ling Zhang, Kaixian Zhang, Min Shi, Yonggang Liu, Ke Zhao, Yidian Wang, Huitao Yu, Zhilong Zhang, Jihong Wang, Lihua Qiao, Xueying Han, Chun Zhu, Shuchai Zhang, Ruohui Chen, Junqiang Hu, Cairong Zhang, Fuquan Hou, Xiaorong Pang, Qingsong Zhang, Wencheng Li, Gaofeng Lin, Hailei Sun, Xinchen Ge, Xiaolin Li, Caihong Ge, Hong Li, Dingjie Wang, Yadi Lu, Na Gao, Xianshu Qin, Shangbin Tian, Yuan Xiao, Zefen Radiat Oncol Research PURPOSE: To investigate the interobserver variability (IOV) in target volume delineation of definitive radiotherapy for thoracic esophageal cancer (TEC) among cancer centers in China, and ultimately improve contouring consistency as much as possible to lay the foundation for multi-center prospective studies. METHODS: Sixteen cancer centers throughout China participated in this study. In Phase 1, three suitable cases with upper, middle, and lower TEC were chosen, and participants were asked to contour a group of gross tumor volume (GTV-T), nodal gross tumor volume (GTV-N) and clinical target volume (CTV) for each case based on their routine experience. In Phase 2, the same clinicians were instructed to follow a contouring protocol to re-contour another group of target volume. The variation of the target volume was analyzed and quantified using dice similarity coefficient (DSC). RESULTS: Sixteen clinicians provided routine volumes, whereas ten provided both routine and protocol volumes for each case. The IOV of routine GTV-N was the most striking in all cases, with the smallest DSC of 0.37 (95% CI 0.32–0.42), followed by CTV, whereas GTV-T showed high consistency. After following the protocol, the smallest DSC of GTV-N was improved to 0.64 (95% CI 0.45–0.83, P = 0.005) but the DSC of GTV-T and CTV remained constant in most cases. CONCLUSION: Variability in target volume delineation was observed, but it could be significantly reduced and controlled using mandatory interventions. SUPPLEMENTARY INFORMATION: Supplementary information accompanies this paper at 10.1186/s13014-020-01691-4. BioMed Central 2021-06-09 /pmc/articles/PMC8188796/ /pubmed/34107984 http://dx.doi.org/10.1186/s13014-020-01691-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chang, Xiao
Deng, Wei
Wang, Xin
Zhou, Zongmei
Yang, Jun
Guo, Wenling
Liu, Miaoling
Qi, Xiaolu
Li, Ling
Zhang, Kaixian
Zhang, Min
Shi, Yonggang
Liu, Ke
Zhao, Yidian
Wang, Huitao
Yu, Zhilong
Zhang, Jihong
Wang, Lihua
Qiao, Xueying
Han, Chun
Zhu, Shuchai
Zhang, Ruohui
Chen, Junqiang
Hu, Cairong
Zhang, Fuquan
Hou, Xiaorong
Pang, Qingsong
Zhang, Wencheng
Li, Gaofeng
Lin, Hailei
Sun, Xinchen
Ge, Xiaolin
Li, Caihong
Ge, Hong
Li, Dingjie
Wang, Yadi
Lu, Na
Gao, Xianshu
Qin, Shangbin
Tian, Yuan
Xiao, Zefen
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
title Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
title_full Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
title_fullStr Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
title_full_unstemmed Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
title_short Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
title_sort interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188796/
https://www.ncbi.nlm.nih.gov/pubmed/34107984
http://dx.doi.org/10.1186/s13014-020-01691-4
work_keys_str_mv AT changxiao interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT dengwei interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT wangxin interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhouzongmei interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT yangjun interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT guowenling interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT liumiaoling interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT qixiaolu interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT liling interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhangkaixian interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhangmin interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT shiyonggang interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT liuke interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhaoyidian interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT wanghuitao interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT yuzhilong interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhangjihong interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT wanglihua interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT qiaoxueying interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT hanchun interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhushuchai interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhangruohui interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT chenjunqiang interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT hucairong interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhangfuquan interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT houxiaorong interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT pangqingsong interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT zhangwencheng interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT ligaofeng interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT linhailei interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT sunxinchen interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT gexiaolin interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT licaihong interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT gehong interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT lidingjie interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT wangyadi interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT luna interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT gaoxianshu interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT qinshangbin interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT tianyuan interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina
AT xiaozefen interobservervariabilityintargetvolumedelineationindefinitiveradiotherapyforthoracicesophagealcanceramulticenterstudyfromchina